je.st
news
Merck KGaA's (MKGAY) "Neutral" Rating Reaffirmed at Goldman Sachs
2016-02-06 15:04:08| Biotech - Topix.net
's stock had its "neutral" rating reissued by research analysts at Goldman Sachs in a note issued to investors on Saturday, AnalystRatings.Net reports. They currently have a $56.00 target price on the stock, down from their previous target price of $60.00.
Tags: rating
neutral
goldman
sachs
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||